![Laura Eichorn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Laura G.
Eichorn was the founder of Imago BioSciences, Inc., founded in 2012, and served as Chief Financial Officer from 2022 to 2023.
Former job includes Vice President-Operations & Finance at FerroKin BioSciences, Inc. Education includes undergraduate studies at Frostburg State University.
Eerdere bekende functies van Laura Eichorn
| Bedrijven | Functie | Einde |
|---|---|---|
| IMAGO BIOSCIENCES, INC. | Oprichter | 01-07-2023 |
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Offers iron chelator for the treatment of iron-overload in patients | Financieel Directeur/CFO | - |
Opleiding van Laura Eichorn
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
5
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Frostburg State University
 Frostburg State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Offers iron chelator for the treatment of iron-overload in patients | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
Kies MarketScreener 
